Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patricia Penovich

Neurology Saint Paul, MN Medical Doctor

NPI 1548287436 CMS profile 70547

225 Smith Ave N, Suite 201, Saint Paul, MN 55102

Open in the dashboard

General payments

$304,304

305 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,214 paid to institutions, not to them · program year 2019

Through program year 2025, Patricia Penovich of Saint Paul, MN is reported in the CMS Open Payments database as having received $304,304 across 305 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,214 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,038 24
2024 General $40,831 37
2023 General $39,809 48
2022 General $75,950 76
2021 General $40,887 42
2020 General $49,941 41
2019 General $25,847 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patricia Penovich
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Patricia Penovich were reported at $31,038. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Patricia Penovich Neurology median Middle half National median
2019 $25,847 $474 $118–$2,177 $163
2020 $49,941 $367 $82–$2,309 $114
2021 $40,887 $438 $104–$2,547 $132
2022 $75,950 $442 $103–$2,388 $149
2023 $39,809 $464 $119–$2,312 $160
2024 $40,831 $468 $119–$2,323 $164
2025 $31,038 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Neurelis, Inc. $175,055 169 payments
  2. Greenwich Biosciences, Inc. $37,811 34 payments
  3. SK Life Science, Inc. $36,870 36 payments
  4. UCB, Inc. $23,870 35 payments
  5. Jazz Pharmaceuticals Inc. $18,731 17 payments
  6. Aquestive Therapeutics, Inc. $6,168 11 payments
  7. Ucb SA $5,400 2 payments
  8. Monteris Medical Corporation $400 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $166,351 74 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $92,378 48 payments
  3. Travel and Lodging $23,239 82 payments
  4. Honoraria $15,550 7 payments
  5. Food and Beverage $6,786 94 payments
Products named General payments · program years 2019–2025
  1. VALTOCO $175,055 169 payments
  2. Epidiolex $56,542 51 payments
  3. XCOPRI $18,406 16 payments
  4. Cenobamate $15,897 18 payments
  5. Nayzilam $10,031 12 payments
  6. SYMPAZAN Neurology $6,151 10 payments
  7. Vimpat $3,959 10 payments
  8. Briviact $1,515 3 payments
  9. NeuroBlate $400 1 payment
  10. SYMPAZAN Neurology $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

305 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record